Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADUS Addus HomeCare	$104.96 -1.7%	$111.90	$88.96 ▼ $136.72	$1.93B	0.8	127,007 shs	199,141 shs
FTRE Fortrea	$5.46 -4.9%	$5.25	$3.97 ▼ $27.26	$494.13M	1.8	1.82 million shs	1.56 million shs
PRVA Privia Health Group	$18.86 -3.4%	$21.62	$16.47 ▼ $26.09	$2.30B	0.8	798,883 shs	766,405 shs
WGS GeneDx	$101.60 -0.3%	$80.02	$25.32 ▼ $117.75	$2.90B	2.02	967,633 shs	835,293 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADUS Addus HomeCare	0.00%	-4.08%	-6.17%	-0.04%	-13.51%
FTRE Fortrea	0.00%	-19.71%	+4.50%	-12.78%	-80.21%
PRVA Privia Health Group	0.00%	-4.26%	-14.70%	-19.13%	-9.06%
WGS GeneDx	0.00%	+27.27%	+10.90%	+51.12%	+210.51%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ADUS Addus HomeCare	4.9418 of 5 stars	3.6	3.0	5.0	4.1	2.5	3.1
FTRE Fortrea	4.1104 of 5 stars	3.9	3.0	0.0	2.3	0.8	3.8
PRVA Privia Health Group	3.901 of 5 stars	3.5	4.0	0.0	2.7	3.3	1.9
WGS GeneDx	3.008 of 5 stars	1.4	4.0	0.0	3.2	5.0	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADUS Addus HomeCare	3.25	Buy	$142.57	35.83% Upside
FTRE Fortrea	1.86	Reduce	$14.00	156.41% Upside
PRVA Privia Health Group	3.00	Buy	$28.38	50.50% Upside
WGS GeneDx	2.75	Moderate Buy	$100.38	-1.21% Downside

Current Analyst Ratings Breakdown

Latest FTRE, PRVA, WGS, and ADUS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2025	WGS GeneDx	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$78.00 ➝ $95.00
7/16/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00
7/11/2025	FTRE Fortrea	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Neutral ➝ Neutral	$8.00 ➝ $7.00
7/9/2025	FTRE Fortrea	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	In-Line ➝ In-Line	$6.00 ➝ $5.00
7/9/2025	PRVA Privia Health Group	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$30.00 ➝ $28.00
7/9/2025	WGS GeneDx	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$110.00
6/30/2025	WGS GeneDx	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$88.00 ➝ $115.00
6/20/2025	ADUS Addus HomeCare	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Outperform	$150.00
6/10/2025	ADUS Addus HomeCare	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$133.00
5/28/2025	PRVA Privia Health Group	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$29.00 ➝ $32.00
5/27/2025	PRVA Privia Health Group	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$23.00 ➝ $24.00

(Data available from 8/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADUS Addus HomeCare	$1.15B	1.67	$5.39 per share	19.47	$53.52 per share	1.96
FTRE Fortrea	$2.70B	0.18	$1.57 per share	3.47	$15.19 per share	0.36
PRVA Privia Health Group	$1.74B	1.32	$0.18 per share	104.52	$5.70 per share	3.31
WGS GeneDx	$305.45M	9.49	$1.02 per share	99.29	$9.71 per share	10.46

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADUS Addus HomeCare	$73.60M	$4.43	23.69	19.58	1.49	6.52%	9.23%	6.96%	8/4/2025 (Estimated)
FTRE Fortrea	-$328.50M	-$8.79	N/A	4.27	0.37	-29.43%	2.84%	1.06%	8/6/2025 (Estimated)
PRVA Privia Health Group	$14.39M	$0.12	157.18	69.85	3.02	0.87%	2.32%	1.38%	8/7/2025 (Estimated)
WGS GeneDx	-$52.29M	$0.05	2,032.00	48.61	N/A	0.39%	16.51%	9.35%	N/A

Latest FTRE, PRVA, WGS, and ADUS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	PRVA Privia Health Group	$0.05	N/A	N/A	N/A	$466.97 million	N/A
8/6/2025	Q2 2025	FTRE Fortrea	$0.06	N/A	N/A	N/A	$631.61 million	N/A
8/4/2025	Q2 2025	ADUS Addus HomeCare	$1.45	N/A	N/A	N/A	$345.71 million	N/A
7/29/2025	Q2 2025	WGS GeneDx	$0.10	$0.50	+$0.40	$0.36	$86.00 million	$102.69 million
5/12/2025	Q1 2025	FTRE Fortrea	-$0.07	$0.02	+$0.09	-$6.25	$609.63 million	$651.30 million
5/5/2025	Q1 2025	ADUS Addus HomeCare	$1.33	$1.42	+$0.09	$1.16	$341.66 million	$337.71 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADUS Addus HomeCare	N/A	N/A	N/A	N/A	N/A
FTRE Fortrea	N/A	N/A	N/A	N/A	N/A
PRVA Privia Health Group	N/A	N/A	N/A	N/A	N/A
WGS GeneDx	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADUS Addus HomeCare	0.20	1.74	1.74
FTRE Fortrea	1.22	0.97	0.97
PRVA Privia Health Group	N/A	1.88	1.88
WGS GeneDx	0.19	2.87	3.07

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADUS Addus HomeCare	95.35%
FTRE Fortrea	N/A
PRVA Privia Health Group	94.48%
WGS GeneDx	61.72%

Insider Ownership

Company	Insider Ownership
ADUS Addus HomeCare	4.60%
FTRE Fortrea	0.38%
PRVA Privia Health Group	10.70%
WGS GeneDx	29.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADUS Addus HomeCare	49,703	18.40 million	17.55 million	Optionable
FTRE Fortrea	15,500	90.50 million	90.16 million	Optionable
PRVA Privia Health Group	1,140	121.92 million	108.88 million	Optionable
WGS GeneDx	1,200	28.53 million	20.09 million	Optionable

FTRE, PRVA, WGS, and ADUS Headlines

Recent News About These Companies

GeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Buy Rating

3 hours ago | marketbeat.com

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. ...

August 2 at 1:17 PM | gurufocus.com

WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

August 2 at 12:52 PM | globenewswire.com

15,317 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Acquired by Universal Beteiligungs und Servicegesellschaft mbH

August 2 at 4:50 AM | marketbeat.com

Wells Fargo & Company Forecasts Strong Price Appreciation for GeneDx (NASDAQ:WGS) Stock

August 2 at 2:07 AM | americanbankingnews.com

Kevin Feeley Sells 388 Shares of GeneDx Holdings Corp. (NASDAQ:WGS) Stock

August 1 at 6:32 PM | marketbeat.com

GeneDx Holdings Corp. (NASDAQ:WGS) CEO Sells $226,837.74 in Stock

August 1 at 6:08 PM | marketbeat.com

Victory Capital Management Inc. Purchases 12,945 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)

August 1 at 6:54 AM | marketbeat.com

GeneDx Holdings Corp. (NASDAQ:WGS) CFO Sells $40,860.28 in Stock

August 1 at 6:26 AM | insidertrades.com

GeneDx Surges Past Q2 Expectations, Sets Up For Strong Year-End Growth

July 31 at 3:48 PM | seekingalpha.com

GeneDx Target of Unusually Large Options Trading (NASDAQ:WGS)

July 31 at 10:59 AM | marketbeat.com

Wells Fargo & Company Issues Positive Forecast for GeneDx (NASDAQ:WGS) Stock Price

July 31 at 10:41 AM | marketbeat.com

WGS Investors Have Opportunity to Join GeneDx Holdings Corp. Investigation With the DJS Law Group

July 31 at 3:30 AM | prnewswire.com

Why GeneDx Holdings Stock Crushed It Again Today

July 30, 2025 | fool.com

GeneDx Holdings Corp. Investors: Company Investigated by the Portnoy Law Firm

July 30, 2025 | globenewswire.com

GeneDx (NASDAQ:WGS) Shares Gap Up Following Strong Earnings

July 30, 2025 | marketbeat.com

GeneDx (NASDAQ:WGS) Announces Quarterly Earnings Results

July 30, 2025 | marketbeat.com

GeneDx CEO on rare disease diagnosis: Earlier testing gives families and clinicians more options

July 30, 2025 | youtube.comY

Earnings To Watch: GeneDx Holdings Corp (WGS) Reports Q2 2025 Result

July 30, 2025 | finance.yahoo.com

GeneDx (NASDAQ:WGS) Shares Gap Up on Strong Earnings

July 30, 2025 | americanbankingnews.com

Why GeneDx Holdings Stock Blasted 8% Higher Today

July 29, 2025 | fool.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FTRE, PRVA, WGS, and ADUS Company Descriptions

Addus HomeCare NASDAQ:ADUS

$104.96 -1.82 (-1.70%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$105.01 +0.05 (+0.05%)

As of 08/1/2025 06:08 PM Eastern

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.

Fortrea NASDAQ:FTRE

$5.46 -0.28 (-4.88%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$6.05 +0.59 (+10.81%)

As of 08/1/2025 07:30 PM Eastern

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Privia Health Group NASDAQ:PRVA

$18.86 -0.66 (-3.38%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$19.00 +0.14 (+0.74%)

As of 08/1/2025 05:52 PM Eastern

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia.

GeneDx NASDAQ:WGS

$101.60 -0.35 (-0.34%)

Closing price 08/1/2025 04:00 PM Eastern

Extended Trading

$100.17 -1.43 (-1.41%)

As of 08/1/2025 07:38 PM Eastern

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time